SPARK Microgravity GmbH
SPARK Microgravity operates the world's first orbital space laboratory for pharmaceutical R&D, providing end-to-end mission services for drug discovery and biotechnology research in microgravity.
Classification
Profile
Funding
Funding details not yet available.
Enables pharmaceutical R&D and biotechnology research in microgravity through the world’s first orbital space laboratory.
Pharmaceutical companies and biotechnology firms seeking drug discovery and rapid hypothesis testing capabilities.
End-to-end mission services including experiment design, payload integration, launch coordination, and on-orbit support.
Direct engagement with specialized industry leaders and presence at high-level space technology forums.
Commercial space stations with standardized docking (IDSS) and visiting vehicles like Dream Chaser for return logistics.
Complex logistics involving payload integration, launch coordination, and on-orbit mission support operations.
The world’s first orbital space laboratory for pharmaceutical R&D and proprietary end-to-end mission service infrastructure.
Orbital pharmaceutical lab operations, experiment design, payload integration, launch coordination, and on-orbit support.
Sales-led service model for high-value, specialized clients requiring complex scientific mission execution.
Unique position as the first orbital pharma lab; competes with commercial space stations enabling rapid 30-60 day research cycles.
Need for controlled downmass, rapid hypothesis testing, and compressed iteration cycles in biotechnology drug discovery.
- Scale Subscription Revenue: Introduce tiered analytics subscriptions (basic, advanced, enterprise) to smooth cash flow and reduce relianc
- Map Customer Journey: Build a detailed funnel (awareness → inquiry → mission design → data delivery) and assign KPI owners for conversion
- Strong Institutional Backing: Partnership with NASA Ames and recent EU Deep-Tech Champion award (2025) demonstrate technical credibility
Team details not yet available.
No investors recorded yet.